PharmaEssentia Corporation Stock Deutsche Boerse AG
Stocks
8Z1
US7169722037
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.50 EUR | -.--% |
|
+11.00% | - |
| 07-09 | PharmaEssentia Swings to Profit in May as Revenue Balloons 108% | MT |
| 06-18 | PharmaEssentia Rebuffs Media Report Speculating Profit, Revenue for 2026 | MT |
| Market Cap | 484B 14.95B 13.06B 12.05B 11.11B 20.94B 1,439B 21.41B 144B 56.67B 705B 56.13B 54.9B 2,427B | P/E 2026 * |
45.1x | P/E 2027 * | 32.8x |
|---|---|---|---|---|---|
| Enterprise Value | 458B 14.13B 12.35B 11.39B 10.5B 19.79B 1,361B 20.23B 136B 53.56B 666B 53.06B 51.9B 2,294B | EV / Sales 2026 * |
18.3x | EV / Sales 2027 * | 13x |
| Free-Float |
75.37% | Yield 2026 * |
0.08% | Yield 2027 * | 0.12% |
| 1 week | +11.00% | ||
| Current month | +11.00% | ||
| 1 month | +11.00% | ||
| 3 months | +11.00% | ||
| 6 months | +11.00% |
| Current year | 13.96 |  | 15.5 |
| 1 year | 13.96 | | 15.5 |
| 3 years | 13.96 | | 15.5 |
| 5 years | 13.96 | | 15.5 |
| 10 years | 13.96 | | 15.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kuo Chung Lin
CEO | Chief Executive Officer | - | 01/01/2003 |
Hsueh Ling Chang
DFI | Director of Finance/CFO | - | 14/10/2015 |
Albert Qin
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ching Liu Chan
CHM | Chairman | - | 01/09/2003 |
Cheng Ku Huang
BRD | Director/Board Member | - | - |
Chao Ho Chen
BRD | Director/Board Member | - | 30/06/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +11.00% | - | - | 15.2B | |
| +0.43% | -0.58% | +56.36% | +57.73% | 53.83B | |
| +5.37% | +0.75% | +50.39% | +83.03% | 52.1B | |
| +0.65% | +0.02% | +6.21% | +412.73% | 23.48B | |
| +1.01% | +2.38% | -15.33% | -14.40% | 23.13B | |
| +3.46% | +0.79% | +34.01% | -4.47% | 19.36B | |
| -1.18% | -2.97% | +32.73% | -33.30% | 17.56B | |
| +3.62% | -2.42% | +29.70% | +663.64% | 14.83B | |
| +0.89% | +0.75% | +27.56% | +184.13% | 14.06B | |
| -2.84% | +1.47% | +62.81% | +152.75% | 12.76B | |
| Average | +1.16% | -1.86% | +31.60% | +166.87% | 25.68B | |
| Weighted average by Cap. | +1.71% | -2.06% | +35.97% | +131.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 25.07B 774M 676M 624M 575M 1.08B 74.49B 1.11B 7.46B 2.93B 36.48B 2.91B 2.84B 126B | 34.57B 1.07B 932M 860M 793M 1.49B 103B 1.53B 10.28B 4.04B 50.31B 4.01B 3.92B 173B |
| Net income | 10.85B 335M 293M 270M 249M 469M 32.26B 480M 3.23B 1.27B 15.8B 1.26B 1.23B 54.38B | 14.97B 462M 404M 373M 343M 647M 44.49B 662M 4.45B 1.75B 21.79B 1.74B 1.7B 75.01B |
| Net Debt | -26.52B -818M -715M -660M -608M -1.15B -78.82B -1.17B -7.89B -3.1B -38.6B -3.07B -3.01B -133B | -34.73B -1.07B -937M -864M -797M -1.5B -103B -1.53B -10.33B -4.06B -50.54B -4.02B -3.94B -174B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6446 Stock
- 8Z1 Stock
Select your edition
All financial news and data tailored to specific country editions
